Sodium stearate

Suppliers

Names

[ CAS No. ]:
822-16-2

[ Name ]:
Sodium stearate

[Synonym ]:
sodium,octadecanoate
Octadecanoic acid, sodium salt (1:1)
Octadecanoic acid sodium salt
octadecanoic acid, sodium salt
Sodium stearate
SODIUM OCTADECANOATE
EINECS 212-490-5
Stearic Acid, Sodium Salt
stearic acid sodium salt
MFCD00036404

Chemical & Physical Properties

[ Density]:
1.103 g/cm3

[ Boiling Point ]:
359.4ºC at 760 mmHg

[ Melting Point ]:
245 - 255ºC

[ Molecular Formula ]:
C18H35NaO2

[ Molecular Weight ]:
306.459

[ Flash Point ]:
162.4ºC

[ Exact Mass ]:
306.253479

[ PSA ]:
40.13000

[ LogP ]:
4.99780

[ Storage condition ]:
2-8°C

[ Stability ]:
Stable. Incompatible with strong oxidizing agents.

[ Water Solubility ]:
SOLUBLE IN COLD AND HOT WATER

MSDS

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
WI4725000
CHEMICAL NAME :
Stearic acid, sodium salt
CAS REGISTRY NUMBER :
822-16-2
LAST UPDATED :
199712
DATA ITEMS CITED :
8
MOLECULAR FORMULA :
C18-H35-O2.Na
MOLECULAR WEIGHT :
306.52
WISWESSER LINE NOTATION :
QV17 &-NA-

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Unreported
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
400 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ATMPA2 Annals of Tropical Medicine and Parasitology. (Grune & Stratton, Inc., POB 6280, Duluth, MN 55806) V.1- 1907- Volume(issue)/page/year: 32,177,1938
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
10 mg/kg
TOXIC EFFECTS :
Vascular - thrombosis distant from injection site
REFERENCE :
JCINAO Journal of Clinical Investigation. (Rockefeller Univ. Press, 1230 York Ave., New York, NY 10021) V.1- 1924- Volume(issue)/page/year: 42,860,1963 *** REVIEWS *** ACGIH TLV-Not classifiable as a human carcinogen DTLVS* The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 Volume(issue)/page/year: TLV/BEI,1997 ACGIH TLV-TWA 10 mg/m3 DTLVS* The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 Volume(issue)/page/year: TLV/BEI,1997 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - 69445 No. of Facilities: 8011 (estimated) No. of Industries: 75 No. of Occupations: 89 No. of Employees: 98215 (estimated) NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - 69445 No. of Facilities: 6021 (estimated) No. of Industries: 60 No. of Occupations: 54 No. of Employees: 98046 (estimated) No. of Female Employees: 35115 (estimated)

Safety Information

[ Personal Protective Equipment ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter

[ Hazard Codes ]:
Xn

[ Safety Phrases ]:
S24/25

[ RIDADR ]:
UN 3077 9/PG 3

[ WGK Germany ]:
1

[ RTECS ]:
WI4725000

[ HS Code ]:
2915709000

Synthetic Route

Precursor & DownStream

Precursor

  • Methanesulfonic acid
  • Methanesulfonic Acid Butyl Ester
  • Butyl stearate
  • stearic acid
  • Sodium formate

DownStream

  • Octadecanoic acid,2-sulfo-
  • Tristealin
  • Silver(I) stearate
  • Copper(2+) dioctadecanoate
  • cobalt(3+),octadecanoate
  • propylene glycol monostearate
  • Methyl undecanoate
  • Methyl myristate
  • Methyl palmitate
  • Methyl stearate

Customs

[ HS Code ]: 2915709000

[ Summary ]:
2915709000. palmitic acid and its salts and esters. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:5.5%. General tariff:30.0%

Articles

Solid lipid nanoparticles for potential doxorubicin delivery in glioblastoma treatment: preliminary in vitro studies.

J. Pharm. Sci. 103(7) , 2157-65, (2014)

The major obstacle to glioblastoma pharmacological therapy is the overcoming of the blood-brain barrier (BBB). In literature, several strategies have been proposed to overcome the BBB: in this experim...

Kinetically stable propofol emulsions with reduced free drug concentration for intravenous delivery.

Int. J. Pharm. 486 , 232-41, (2015)

Intravenous injections of propofol emulsions are accompanied by pain likely due to the interaction of the dissolved drug with endothelial cells of the vasculature. It is commonly hypothesized that red...

A drug formulation using an alginate hydrogel matrix for efficient oral delivery of the manganese porphyrin-based superoxide dismutase mimic.

Biomater. Sci. 3 , 861-9, (2015)

In order for patients to avail of the therapeutic benefits of antioxidant drugs efficiently and conveniently, a robust oral delivery system needs to be developed. However, a common problem in oral dru...


More Articles


Related Compounds

  • sodium 2-sulphonatoethyl hydrogen stearate
  • sodium 2-hydroxy-3-sulphonatopropyl stearate
  • sodium 6-amino-5-[[3-[(ethylphenylamino)sulphonyl]phenyl]azo]-4-hydroxynaphthalene-2-sulphonate
  • sodium hydrogen 2-hydroxy-3-sulphonatopropyl 5-carboxylato-4-hexylcyclohex-2-ene-1-octanoate
  • sodium,5-oxo-2-phenyloxolane-2-carboxylate
  • sodium,dimethyl-bis(prop-2-enyl)azanium,prop-2-enamide,prop-2-enoate,chloride